Proposed $1B opioid class action against some drug firms cancelled due to lack of lead plaintiff
The Ontario Superior Court of Justice has dropped a pharmaceutical company and its affiliates from an ongoing proposed opioids class action against various manufacturers that alleges promotion of opioid use leading...To view the full article, register now.
Already a subscriber? Click here to view full article